Life AI Net
Inicio
Archivo
Calculadoras
Directorio
Boletín
Hot
Iniciar sesión
Español
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Inicio
Archivo
Calculadoras
Directorio
Boletín
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Iniciar sesión
Inicio
Archivo
Calculadoras
Directorio
More
En vivo
Lonza News
Is Lonza Group (SWX:LONN) Pricing Too High After Recent Share Price Swings? - Yahoo Finance
Thermo Fisher
TMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Investment Community Signals - UBND thành phố Hải Phòng
FierceBiotech
Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
Thermo Fisher
Thermo Fisher (TMO) Q4 2024 Earnings Transcript - AOL.com
Waters
WAT (Waters Corporation) rises 1.06 percent after Q4 2025 results, as 7 percent revenue growth offsets minor EPS miss. - Earnings Risk - Cổng thông tin điện tử Tỉnh Sơn La
FierceBiotech
McKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B
FierceBiotech
AcuityMD raises $80M to help bolster AI in the medtech industry
FierceBiotech
AACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’
FierceBiotech
Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
BioWorld
Appointments and advancements for April 22, 2026
BioWorld
Financings for April 22, 2026
BioWorld
In the clinic for April 22, 2026
Lonza News
Is Lonza Group (SWX:LONN) Pricing Too High After Recent Share Price Swings? - Yahoo Finance
Thermo Fisher
TMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Investment Community Signals - UBND thành phố Hải Phòng
FierceBiotech
Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
Thermo Fisher
Thermo Fisher (TMO) Q4 2024 Earnings Transcript - AOL.com
Waters
WAT (Waters Corporation) rises 1.06 percent after Q4 2025 results, as 7 percent revenue growth offsets minor EPS miss. - Earnings Risk - Cổng thông tin điện tử Tỉnh Sơn La
FierceBiotech
McKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B
FierceBiotech
AcuityMD raises $80M to help bolster AI in the medtech industry
FierceBiotech
AACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’
FierceBiotech
Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
BioWorld
Appointments and advancements for April 22, 2026
BioWorld
Financings for April 22, 2026
BioWorld
In the clinic for April 22, 2026
Archivo
BioWorld
2 feb 2026
In the clinic for Feb. 2, 2026
In the clinic for Feb. 2, 2026
Original
Contenido no disponible. Consulta la fuente original.